Director, Clinical Development (MD)

Scorpion Therapeutics; Santa Monica (CA); On-site; USD 200,000 - 260,000; Full time

Job summary

Scorpion Therapeutics seeks a Medical Director to provide clinical oversight for early‑phase oncology/autoimmune trials, with emphasis on CAR T-cell immunotherapy in cancer. Responsibilities include protocol design, trial documentation review, and cross‑functional collaboration to advance program milestones.

The ideal candidate holds an MD/DO with 2–5 years in clinical/development, solid GCP knowledge, and Neurology specialization or eligibility, plus expertise in neuroimmunology.

Qualifications

• MD or DO required; 2-5 years in clinical or drug development preferable.
• Knowledge of Good Clinical Practice (GCP) and trial design.
• Preference for board certification or eligibility in Neurology; expertise in neuroimmunology/autoimmune neurologic diseases.

Responsibilities

• Design and implement clinical protocols for multiple trials in neurology/autoimmune diseases.
• Review trial documents and medical/regulatory submissions.
• Engage investigators and sites; support trial execution and data integrity.
• Contribute to regulatory submissions and external scientific interactions.

Skills

GCP knowledge

Clinical trial design

Regulatory submissions

Investigator engagement

Medical leadership

Education

MD/DO

Job description

Role: Medical Director providing clinical oversight and monitoring for multiple trials in neurology and/or autoimmune disease, focusing on early-phase and proof-of-concept studies in cancer immunotherapy, particularly CAR T-cell therapies.

Responsibilities include designing and implementing clinical protocols, reviewing trial documents, engaging investigators, supporting trial execution, and contributing to regulatory submissions and external scientific interactions.

Requirements: MD or DO, 2-5 years of clinical or drug development experience, knowledge of GCP, clinical trial design, with a preference for board certification or eligibility in Neurology, and expertise in neuroimmunology or autoimmune neurologic diseases.

High-Value: early-phase oncology/autoimmune trials, immunotherapy modalities (CAR T-cells), regulatory engagement, cross-functional collaboration with regulatory, safety, clinical operations, biometrics, and translational sciences.

Work setup may involve up to 25% travel; location specifics are not detailed but the role involves strategic and operational leadership in cancer therapeutics development.